On the other hand, the CRF1 antagonists, CP-316,311, showed no effect against depression in a 6-week randomized, placebo-controlled trial [18] and pexacerfont did not demonstrate efficacy compared to placebo for the treatment of generalized anxiety disorders in a multi-center clinical trial [19]. The gene discussed is CRHR1; the disease is depressive disorder.